Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of High Surgical Risk Patients With Severe Mitral Regurgitation Treated With the Cardiovalve Transfemoral Mitral Valve System

NCT03714412 is registered in ClinicalTrials.gov with Cardiovalve Ltd. as lead sponsor.

NCT NCT03714412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03714412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of High Surgical Risk Patients With Severe Mitral Regurgitation Treated With the Cardiovalve Transfemoral Mitral Valve System
Lead sponsor
Cardiovalve Ltd.
Phase
Not applicable
Overall status
Withdrawn
Start date
September 30, 2019
Completion date
December 15, 2023
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation